These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Antimicrobial therapy for rheumatoid arthritis. Kloppenburg M; Dijkmans BA; Breedveld FC Baillieres Clin Rheumatol; 1995 Nov; 9(4):759-69. PubMed ID: 8591652 [TBL] [Abstract][Full Text] [Related]
47. A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury. Nieman GF; Zerler BR Curr Med Chem; 2001 Feb; 8(3):317-25. PubMed ID: 11172686 [TBL] [Abstract][Full Text] [Related]
48. [Therapeutic news of 1975]. Luyckx A; Van Cauwenberge H Rev Med Liege; 1976 Apr; 31(8):267-80. PubMed ID: 13473 [No Abstract] [Full Text] [Related]
49. Potential of tetracyclines to modify cartilage breakdown in osteoarthritis. Ryan ME; Greenwald RA; Golub LM Curr Opin Rheumatol; 1996 May; 8(3):238-47. PubMed ID: 8796985 [TBL] [Abstract][Full Text] [Related]
50. Tetracyclines-An Important Therapeutic Tool for Dermatologists. Orylska-Ratynska M; Placek W; Owczarczyk-Saczonek A Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742496 [TBL] [Abstract][Full Text] [Related]
51. [Betamethasone in current practice]. Coadou LJ Sem Ther; 1965 Dec; 41(10):582-4. PubMed ID: 5298346 [No Abstract] [Full Text] [Related]
52. New uses for tetracyclines. J Am Dent Assoc; 1997 Jul; 128(7):822, 826. PubMed ID: 9231598 [No Abstract] [Full Text] [Related]
53. Tetracyclines: drugs with huge therapeutic potential. Bahrami F; Morris DL; Pourgholami MH Mini Rev Med Chem; 2012 Jan; 12(1):44-52. PubMed ID: 22070692 [TBL] [Abstract][Full Text] [Related]
54. [Therapeutic update 1997-1998 (1). First part]. Scheen AJ Rev Med Liege; 1998 Aug; 53(8):459-66. PubMed ID: 9810205 [TBL] [Abstract][Full Text] [Related]
55. Chemical and biological dynamics of tetracyclines. Nelson ML Adv Dent Res; 1998 Nov; 12(2):5-11. PubMed ID: 9972116 [No Abstract] [Full Text] [Related]
56. Matching quality of agents employed in "double-blind" controlled clinical trials. Hill LE; Nunn AJ; Fox W Lancet; 1976 Feb; 1(7955):352-6. PubMed ID: 54755 [TBL] [Abstract][Full Text] [Related]
57. [Current status of therapeutic agents 1987-1988]. Scheen A; Van Cauwenberge H Rev Med Liege; 1988 May; 43(9):354-64. PubMed ID: 3387728 [No Abstract] [Full Text] [Related]
58. Non-antimicrobial and antimicrobial tetracyclines inhibit IL-6 expression in murine osteoblasts. Kirkwood KL; Golub LM; Bradford PG Ann N Y Acad Sci; 1999 Jun; 878():667-70. PubMed ID: 10415803 [No Abstract] [Full Text] [Related]
59. Antibiotic use and risk of myocardial infarction. Golub LM; Greenwald RA; Thompson RW JAMA; 1999 Dec; 282(21):1997-8; author reply 1999. PubMed ID: 10591376 [No Abstract] [Full Text] [Related]
60. Tetracyclines: four rings to rule infections through resistance and disease tolerance. Jesus K; Moita LF J Clin Invest; 2022 Sep; 132(17):. PubMed ID: 36047498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]